Eric Dobmeier
Directeur/Bestuurslid bij ATARA BIOTHERAPEUTICS, INC.
Vermogen: 354 428 $ op 30-04-2024
Actieve functies van Eric Dobmeier
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ATARA BIOTHERAPEUTICS, INC. | Directeur/Bestuurslid | 26-03-2015 | - |
Independent Dir/Board Member | 26-03-2015 | - | |
STRUCTURE THERAPEUTICS INC. | Directeur/Bestuurslid | 01-12-2022 | - |
Independent Dir/Board Member | 01-12-2022 | - | |
Chinook Therapeutics U.S., Inc.
Chinook Therapeutics U.S., Inc. Information Technology ServicesTechnology Services Chinook Therapeutics U.S., Inc. operates as a development stage company. The company is headquartered in Seattle, WA. | Directeur/Bestuurslid | - | - |
Algemeen Directeur | - | - | |
President | - | - |
Loopbaan van Eric Dobmeier
Eerdere bekende functies van Eric Dobmeier
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
CHINOOK THERAPEUTICS, INC. | Algemeen Directeur | 07-10-2020 | 11-08-2023 |
Voorzitter | 07-10-2020 | 11-08-2023 | |
President | 07-10-2020 | 11-08-2023 | |
ADAPTIVE BIOTECHNOLOGIES CORPORATION | Directeur/Bestuurslid | 01-09-2016 | 17-03-2021 |
Independent Dir/Board Member | 01-09-2016 | 17-03-2021 | |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Directeur/Bestuurslid | 01-06-2017 | 12-10-2018 |
STEMLINE THERAPEUTICS, INC. | Directeur/Bestuurslid | 01-04-2012 | 21-06-2018 |
Independent Dir/Board Member | 01-04-2012 | 21-06-2018 | |
ARS PHARMACEUTICALS, INC. | Algemeen Directeur | 01-01-2018 | 01-06-2018 |
President | 01-01-2018 | 01-06-2018 | |
SEAGEN INC. | Operationeel Directeur | 18-06-2011 | 01-01-2018 |
Bedrijfssecretaris | 03-06-2009 | 28-11-2014 | |
░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░░ | - | - | |
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░ ░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Opleiding van Eric Dobmeier
Princeton University | Undergraduate Degree |
Berkeley Law University of California | Graduate Degree |
Statistieken
Internationaal
Verenigde Staten | 14 |
Canada | 2 |
Operationeel
Director/Board Member | 8 |
President | 5 |
Independent Dir/Board Member | 4 |
Sectoraal
Health Technology | 8 |
Commercial Services | 5 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
ATARA BIOTHERAPEUTICS, INC. | Health Technology |
ADAPTIVE BIOTECHNOLOGIES CORPORATION | Health Technology |
STRUCTURE THERAPEUTICS INC. | Commercial Services |
Bedrijven in privébezit | 9 |
---|---|
Seagen Inc.
Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
Venture Law Group
Venture Law Group Miscellaneous Commercial ServicesCommercial Services Venture Law Group provided law and legal services. The firm specialized in mergers and acquisitions, bankruptcy and restructuring, taxation, labor and employment, intellectual property, technology licensing, corporate partnerships, and executive compensation. The company was founded in 1993 and is headquartered in Menlo Park, CA. | Commercial Services |
Stemline Therapeutics, Inc.
Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Stemline Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, acquisition, development, and commercialization of novel therapeutics for oncology indications of unmet medical need. Its clinical stage product candidates include SL-401, SL-801, and SL-701. The SL-401, is a targeted therapy directed to the interleukin-3 receptor (CD123) present on a malignancies. The SL-801, is a novel oral small molecule reversible inhibitor of XPO1, that has demonstrated in vivo and in vitro preclinical activity in solid and hematologic malignancies. The SL-701, is an immunotherapy designed to activate the immune system to attack tumors. The company was founded by Ivan Bergstein on August 8, 2003 and is headquartered in New York, NY. | Health Technology |
Heller Ehrman LLP
Heller Ehrman LLP Miscellaneous Commercial ServicesCommercial Services Heller Ehrman LLP provides legal services. It offers litigation, business, and intellectual property services. The company was founded in 1980 and is headquartered in San Francisco, CA. | Commercial Services |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Health Technology |
Silverback Therapeutics, Inc.
Silverback Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Silverback Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the proprietary ImmunoTAC technology platform to develop systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases. The company was founded by Peter A. Thompson January 4, 2016 and is headquartered in Seattle, WA. | Health Technology |
Chinook Therapeutics, Inc. /Old/
Chinook Therapeutics, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Chinook Therapeutics, Inc operates as a biotechnology company, which engages in the development of medicines for kidney diseases. The company is headquartered in Vancouver, Canada. | Commercial Services |
Chinook Therapeutics U.S., Inc.
Chinook Therapeutics U.S., Inc. Information Technology ServicesTechnology Services Chinook Therapeutics U.S., Inc. operates as a development stage company. The company is headquartered in Seattle, WA. | Technology Services |
Chinook Therapeutics, Inc.
Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA. | Health Technology |
- Beurs
- Insiders
- Eric Dobmeier
- Ervaring